- Home
- LUCY vs BGLC Comparison
LUCY vs BGLC Comparison
Compare LUCY & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- BGLC
- Stock Information
- Founded
- LUCY 2017
- BGLC 2017
- Country
- LUCY United States
- BGLC Malaysia
- Employees
- LUCY N/A
- BGLC N/A
- Industry
- LUCY Ophthalmic Goods
- BGLC Medical Specialities
- Sector
- LUCY Health Care
- BGLC Health Care
- Exchange
- LUCY Nasdaq
- BGLC Nasdaq
- Market Cap
- LUCY 8.9M
- BGLC 10.4M
- IPO Year
- LUCY 2022
- BGLC N/A
- Fundamental
- Price
- LUCY $1.92
- BGLC $5.69
- Analyst Decision
- LUCY
- BGLC
- Analyst Count
- LUCY 0
- BGLC 0
- Target Price
- LUCY N/A
- BGLC N/A
- AVG Volume (30 Days)
- LUCY 101.5K
- BGLC 57.9K
- Earning Date
- LUCY 08-14-2025
- BGLC 08-18-2025
- Dividend Yield
- LUCY N/A
- BGLC N/A
- EPS Growth
- LUCY N/A
- BGLC N/A
- EPS
- LUCY N/A
- BGLC N/A
- Revenue
- LUCY $1,978,018.00
- BGLC $9,551,559.00
- Revenue This Year
- LUCY $367.48
- BGLC N/A
- Revenue Next Year
- LUCY $166.67
- BGLC N/A
- P/E Ratio
- LUCY N/A
- BGLC N/A
- Revenue Growth
- LUCY 29.30
- BGLC 4.01
- 52 Week Low
- LUCY $1.57
- BGLC $2.01
- 52 Week High
- LUCY $11.16
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- LUCY 42.49
- BGLC 52.95
- Support Level
- LUCY $1.94
- BGLC $5.45
- Resistance Level
- LUCY $2.07
- BGLC $5.81
- Average True Range (ATR)
- LUCY 0.11
- BGLC 0.22
- MACD
- LUCY 0.00
- BGLC -0.02
- Stochastic Oscillator
- LUCY 12.82
- BGLC 77.78
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.